Document Detail


Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome.
MedLine Citation:
PMID:  19732872     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In an attempt to evaluate the effect of random timing of the start of clomiphene citrate (CC) treatment in anovulatory patients with polycystic ovary syndrome on treatment characteristics and outcome, with no regard to time of menstruation, we studied 291 women in their first CC treatment cycle. Duration of treatment was shorter by 2 days and number of leading follicles was higher when treatment was started late (7-29 days from starting a bleed, as compared with day 5), but no effect of starting day was observed on response rate to CC, maximal E(2) level, endometrial thickness, and pregnancy rate.
Authors:
Jacob Farhi; Raoul Orvieto; Roy Homburg
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study     Date:  2009-09-03
Journal Detail:
Title:  Fertility and sterility     Volume:  93     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-04-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2077-9     Citation Subset:  IM    
Copyright Information:
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Affiliation:
Infertility and IVF Unit, Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, Israel. j_farhi@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Clomiphene / administration & dosage*
Drug Administration Schedule
Endometrium / drug effects,  pathology
Estradiol / blood
Female
Fertility Agents, Female / administration & dosage
Humans
Infertility, Female / blood,  drug therapy*,  etiology,  pathology
Male
Menstruation / drug effects*,  physiology
Ovarian Follicle / drug effects,  physiology
Ovulation Induction / methods*
Polycystic Ovary Syndrome / blood,  complications,  drug therapy*,  pathology
Pregnancy
Pregnancy Rate
Treatment Outcome
Withholding Treatment
Young Adult
Chemical
Reg. No./Substance:
0/Fertility Agents, Female; 50-28-2/Estradiol; 911-45-5/Clomiphene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Done wrong or said wrong? Young children understand the normative directions of fit of different spe...
Next Document:  Caffeine consumption and miscarriage: a prospective cohort study.